425 related articles for article (PubMed ID: 32380740)
1. The Role of Bacterial Membrane Vesicles in the Dissemination of Antibiotic Resistance and as Promising Carriers for Therapeutic Agent Delivery.
Uddin MJ; Dawan J; Jeon G; Yu T; He X; Ahn J
Microorganisms; 2020 May; 8(5):. PubMed ID: 32380740
[TBL] [Abstract][Full Text] [Related]
2. Research Progress on Bacterial Membrane Vesicles and Antibiotic Resistance.
Liu X; Xiao J; Wang S; Zhou J; Qin J; Jia Z; Wang Y; Wang Z; Zhang Y; Hao H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232856
[TBL] [Abstract][Full Text] [Related]
3. Methods of Bacterial Membrane Vesicle Production, Purification, Quantification, and Examination of Their Immunogenic Functions.
Bitto NJ; Kaparakis-Liaskos M
Methods Mol Biol; 2022; 2523():43-61. PubMed ID: 35759190
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory roles and novel applications of bacterial membrane vesicles.
Gilmore WJ; Johnston EL; Zavan L; Bitto NJ; Kaparakis-Liaskos M
Mol Immunol; 2021 Jun; 134():72-85. PubMed ID: 33725501
[TBL] [Abstract][Full Text] [Related]
5. Considerations for the Analysis of Bacterial Membrane Vesicles: Methods of Vesicle Production and Quantification Can Influence Biological and Experimental Outcomes.
Bitto NJ; Zavan L; Johnston EL; Stinear TP; Hill AF; Kaparakis-Liaskos M
Microbiol Spectr; 2021 Dec; 9(3):e0127321. PubMed ID: 34937167
[TBL] [Abstract][Full Text] [Related]
6. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy.
Long Q; Zheng P; Zheng X; Li W; Hua L; Yang Z; Huang W; Ma Y
Adv Drug Deliv Rev; 2022 Jul; 186():114321. PubMed ID: 35533789
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis Mediated by Bacterial Membrane Vesicles.
Gilmore WJ; Bitto NJ; Kaparakis-Liaskos M
Subcell Biochem; 2021; 97():101-150. PubMed ID: 33779916
[TBL] [Abstract][Full Text] [Related]
8. Bacterial membrane vesicles as novel nanosystems for drug delivery.
Jain S; Pillai J
Int J Nanomedicine; 2017; 12():6329-6341. PubMed ID: 28919737
[TBL] [Abstract][Full Text] [Related]
9. Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer.
Gao J; Su Y; Wang Z
Adv Drug Deliv Rev; 2022 Jul; 186():114340. PubMed ID: 35569561
[TBL] [Abstract][Full Text] [Related]
10. Production and purification of bacterial membrane vesicles for biotechnology applications: Challenges and opportunities.
Castillo-Romero KF; Santacruz A; González-Valdez J
Electrophoresis; 2023 Jan; 44(1-2):107-124. PubMed ID: 36398478
[TBL] [Abstract][Full Text] [Related]
11. Bacterial Membrane Vesicles as Smart Drug Delivery and Carrier Systems: A New Nanosystems Tool for Current Anticancer and Antimicrobial Therapy.
Aytar Çelik P; Erdogan-Gover K; Barut D; Enuh BM; Amasya G; Sengel-Türk CT; Derkus B; Çabuk A
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111538
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of Bacterial Extracellular Vesicles.
Chen J; Zhang H; Wang S; Du Y; Wei B; Wu Q; Wang H
Front Microbiol; 2022; 13():835058. PubMed ID: 35283837
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic Bacterial Membrane Vesicles for Drug Delivery Applications.
Fazal S; Lee R
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575506
[TBL] [Abstract][Full Text] [Related]
14. The food safety perspective of antibiotic resistance.
McDermott PF; Zhao S; Wagner DD; Simjee S; Walker RD; White DG
Anim Biotechnol; 2002 May; 13(1):71-84. PubMed ID: 12212946
[TBL] [Abstract][Full Text] [Related]
15. Bacterial membrane vesicle functions, laboratory methods, and applications.
Aytar Çelik P; Derkuş B; Erdoğan K; Barut D; Blaise Manga E; Yıldırım Y; Pecha S; Çabuk A
Biotechnol Adv; 2022; 54():107869. PubMed ID: 34793882
[TBL] [Abstract][Full Text] [Related]
16. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
[TBL] [Abstract][Full Text] [Related]
17. Bacterial membrane vesicles for vaccine applications.
Krishnan N; Kubiatowicz LJ; Holay M; Zhou J; Fang RH; Zhang L
Adv Drug Deliv Rev; 2022 Jun; 185():114294. PubMed ID: 35436569
[TBL] [Abstract][Full Text] [Related]
18. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
Gupta V; Datta P
Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
[TBL] [Abstract][Full Text] [Related]
19. Bacterial genome engineering and synthetic biology: combating pathogens.
Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
[TBL] [Abstract][Full Text] [Related]
20. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
